Dice CEO: Energy, T...
Health Care: Drugs
DUSA Pharmaceuticals Inc. (DUSA: NASDAQ)
$4.91 -0.25 | -4.84%
06/01/12 - 04:00 PM ET
Company Balance Sheet
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 24.42M | 8.88M | 7.61M | 3.88M |
| Receivables | 3.73M | 3.31M | 2.63M | 2.52M |
| Inventories | 2.82M | 2.17M | 2.17M | 2.81M |
| Other Current Assets | 38.67K | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 36.19M | 26.47M | 23.03M | 25.94M |
| Property, Plant & Equipment, Gross | 10.31M | 9.84M | 9.53M | 9.35M |
| Accumulated Depreciation & Depletion | 8.71M | 8.26M | 7.87M | 7.41M |
| Property, Plant & Equipment, Net | 1.60M | 1.58M | 1.66M | 1.94M |
| Intangibles | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Assets | 233.64K | 242.85K | 242.35K | 335.00K |
| Total Non-Current Assets | 1.83M | 1.83M | 1.90M | 2.27M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 38.02M | 28.29M | 24.93M | 28.21M |
| Accounts Payable | 803.64K | 162.74K | 630.14K | 306.00K |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 851.78K | 0.00 | 0.00 | 0.00 |
| Total Current Liabilities | 6.47M | 5.47M | 5.25M | 5.66M |
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 3.27M | 3.30M | 3.84M | 4.84M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 3.27M | 3.30M | 3.84M | 4.84M |
| Total Liabilities | 9.74M | 8.77M | 9.09M | 10.50M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 28.28M | 19.52M | 15.84M | 17.71M |
| Common Par | 151.99M | 0.00 | 0.00 | 0.00 |
| Additional Paid In Capital | 10.61M | 161.10M | 159.98M | 159.18M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -134.34M | -141.66M | -144.36M | -141.85M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 25.60K | 77.18K | 225.49K | 384.00K |
| Total Capitalization | 28.28M | 19.52M | 15.84M | 17.71M |
| Total Equity | 28.28M | 19.52M | 15.84M | 17.71M |
| Total Liabilities & Stock Equity | 38.02M | 28.29M | 24.93M | 28.21M |
| Total Common Shares Outstanding | 24.65M | 24.24M | 24.11M | 24.09M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 40.00K |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 24.53M | 24.19M | 24.10M | 24.08M |
| Diluted Weighted Shares Outstanding | 26.35M | 24.77M | 24.10M | 24.08M |
| Number of Employees | 96 | 85 | 84 | 84 |
| Number of Part-Time Employees | 0 | 1 | 2 | 2 |
Portfolios with DUSA
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorTop-Rated Biotechnology Stocks
- UserThatBobGuy Portfolio 1
- ContributorBarron's Insider Purchases ...
- ContributorTop 10 Insider Purchases: J...
- Userjoshuparks Portfolio 1
- Uservladys buttom fishing
- Userbill 3
- UserHeld's
Latest DUSA Headlines from TheStreet
- 8 Stocks Under $10 Ripping Higher 05.03.12 | 01:05 pm
- DUSA Pharmaceuticals Inc. Stock Upgraded (DUSA) 11.14.11 | 06:11 am
- DUSA Pharmaceuticals Inc. Stock Downgraded (DUSA) 07.28.11 | 07:07 am
- DUSA Stock Hits New 52-Week High (DUSA) 05.25.11 | 10:05 am
- DUSA Stock Soars (DUSA) 05.05.11 | 10:05 am
- DUSA Pharmaceuticals Inc. Stock Upgraded (DUSA) 03.04.11 | 05:03 pm
- DUSA Stock Soars Higher (DUSA) 03.03.11 | 10:03 am
- Cautious Bull
03.08.10 | 11:03 am - The Pisani Paradox 09.28.09 | 11:09 am
- Wednesday's Health Winners & Losers 10.03.07 | 03:10 pm
Press Releases for DUSA
- DUSA Pharmaceuticals, Inc.® To Host First Quarter 2011 Corporate Highlights And Financial Results Webcast And Conference Call - Business Wire 04.28.11 | 08:04 am
- A Patient Receiving Levulan Photodynamic Therapy. (Photo: Business Wire) - Business Wire 03.03.11 | 06:03 am
- DUSA Pharmaceuticals, Inc.® To Host Fourth Quarter And Full Year 2010 Corporate Highlights And Financial Results Conference Call - Business Wire 02.25.11 | 06:02 am
- DUSA Pharmaceuticals To Present At The 4th Annual Maxim Group Growth Conference - PR Newswire 11.11.10 | 08:11 am
- DUSA Pharmaceuticals Named To Deloitte's 2010 Technology Fast 500 List Of Fastest Growing Companies In North America - PR Newswire 10.26.10 | 03:10 pm
- DUSA Pharmaceuticals To Present At The Rodman & Renshaw 12th Annual Healthcare Conference - PR Newswire 09.07.10 | 08:09 am
- DUSA Pharmaceuticals Receives Response From FDA On Orphan Drug Designation Status - PR Newswire 08.06.10 | 12:08 pm
- DUSA Pharmaceuticals Reports U.S. Patent Office Upholds Key Photodynamic Therapy Patent - PR Newswire 06.24.10 | 06:06 am
- DUSA Pharmaceuticals Announces Slate Of Nominees For Election To The Board Of Directors - PR Newswire 05.13.10 | 12:05 pm
- DUSA Pharmaceuticals Reports Notice Of Allowance For Key PDT Device Patent - PR Newswire 05.07.10 | 06:05 am
Partner Headlines for DUSA
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 03.30.12 | 09:03 am
- DUSA Pharmaceuticals Is A Small Gem - Seeking Alpha 12.23.11 | 02:12 pm
- 20 Smart Money Stock Picks Trading Under $5 - Seeking Alpha 11.03.11 | 07:11 am
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 07.01.11 | 09:07 am
- Zacks #1 Rank Additions for Monday - Tale of the Tape - Zacks 03.07.11 | 09:03 am
- Morning Market Movers (GTEC, ASGR, LSBK, DUSA) - Benzinga 03.03.11 | 09:03 am
- UPDATE 1-DUSA to end skin drug deal with Stiefel Laboratories - Reuters 10.06.10 | 08:10 am
- UPDATE 1-DUSA to stop cancer trial as FDA denies orphan status - Reuters 08.06.10 | 02:08 pm
